Additionally, one of the SNPs identified in the 3-way GMDR 0.9 analysis, MMP2.rs11639960, is an eQTL, affecting the expression levels of the gene called LPCAT2. LPCAT2 is known to affect response to chemotherapy in colorectal cancer patients through an association with lipid droplet formation (Cotte et al., 2018). This evidence concerns the gene LPCAT2 and colorectal cancer.